Multi-Omics Analysis Reveals Translational Landscapes and Regulations in Mouse and Human Oocyte Aging

Adv Sci (Weinh). 2023 Sep;10(26):e2301538. doi: 10.1002/advs.202301538. Epub 2023 Jul 3.

Abstract

Abnormal resumption of meiosis and decreased oocyte quality are hallmarks of maternal aging. Transcriptional silencing makes translational control an urgent task during meiosis resumption in maternal aging. However, insights into aging-related translational characteristics and underlying mechanisms are limited. Here, using multi-omics analysis of oocytes, it is found that translatomics during aging is related to changes in the proteome and reveals decreased translational efficiency with aging phenotypes in mouse oocytes. Translational efficiency decrease is associated with the N6-methyladenosine (m6A) modification of transcripts. It is further clarified that m6A reader YTHDF3 is significantly decreased in aged oocytes, inhibiting oocyte meiotic maturation. YTHDF3 intervention perturbs the translatome of oocytes and suppress the translational efficiency of aging-associated maternal factors, such as Hells, to affect the oocyte maturation. Moreover, the translational landscape is profiled in human oocyte aging, and the similar translational changes of epigenetic modifications regulators between human and mice oocyte aging are observed. In particular, due to the translational silence of YTHDF3 in human oocytes, translation activity is not associated with m6A modification, but alternative splicing factor SRSF6. Together, the findings profile the specific translational landscapes during oocyte aging in mice and humans, and uncover non-conservative regulators on translation control in meiosis resumption and maternal aging.

Keywords: Hells; YTHDF3; m6A modifications; oocyte aging; translatomics.

MeSH terms

  • Adenosine
  • Aged
  • Animals
  • Humans
  • Meiosis / genetics
  • Mice
  • Multiomics*
  • Oocytes*
  • Phosphoproteins
  • Serine-Arginine Splicing Factors

Substances

  • Adenosine
  • SRSF6 protein, human
  • Serine-Arginine Splicing Factors
  • Phosphoproteins